ImetelChat

Inspire Medical Systems (NASDAQ: INSP) faces heightened execution risk following a sharp 2025 earnings guidance cut tied to weak Inspire V adoption and operational missteps, including staffing and billing issues; the resulting class-action lawsuits underscore investor concerns about management ...

Well said, Biopearl! I never got any response either when I asked about Dr. Feller.

Geron - Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies
Inbox

I too emailed them last week and have not heard back.

I never received approval or rejection when I registered for Dr. Feller's seminar. So I did not see or hear it. Hmm.

The Feller situation is interesting. I followed your post up by registering for Dr. Feller's seminar. My application is pending approval.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF
SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or
Section ...

I sold 2/3 of my geron a couple of weeks ago. I bought back a few last night. Pretty sluggish development of stock. If new team doesn’t show life I will vacate. I like some other biotechs better.

Four new executives appointed, including new Chief Commercial Officer, to lead commercial strategy and operations
FOSTER CITY, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of ...

Kura Oncology, Inc. (NASDAQ: KURA) is a clinical-stage oncology company developing precision therapies for genetically defined cancers. With a market capitalization near $890 million, a public float of 73.9 million shares, and a cash runway extending beyond 2026, Kura maintains a strong balance ...

How is it you can get messages from Yahoo discussion board? Do you pay for their services? I am no longer able to get any messages via their conversation slot. It's been inaccessible for about a week or so.

Scholar Rock (NASDAQ: SRRK) announced that the FDA issued a Complete Response Letter (CRL) for its Biologics License Application (BLA) for apitegromab, a therapy for Spinal Muscular Atrophy (SMA). The rejection was not due to concerns about the drug's safety or efficacy but rather manufacturing ...

Great review. Thanks!

I am not getting any of the conversations in Yahoo boards last two days. Anyone else coming up blank for conversations?

I find it very hard not to be impatient.

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that management is scheduled to participate in a fireside chat on September 4, 2025 at the 2025 Wells Fargo Healthcare Conference in Boston, MA.

A live webcast of ...

Pretty impressive. Thanks!

I really appreciate your efforts and the outcome, Fish Jr.!

Thank you for clarifying tariff situation!

Does Geron still have a supplier in India? If so, do the new tariffs on India imports impact Geron?